These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34836744)

  • 1. Neuroprotective effect of pseudoginsenoside-F11 on permanent cerebral ischemia in rats by regulating calpain activity and NR2A submit-mediated AKT-CREB signaling pathways.
    Liu Y; Fu X; Liu Y; Zhang T; Cui P; Wang S; Liu L; Hou Z; Wang H; Zhao Y; Zhang Z; Zhang H; Wu C; Yang J
    Phytomedicine; 2022 Feb; 96():153847. PubMed ID: 34836744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoginsenoside F11 ameliorates the dysfunction of the autophagy-lysosomal pathway by activating calcineurin-mediated TFEB nuclear translocation in neuron during permanent cerebral ischemia.
    Fu X; Liu Y; Zhang H; Yu X; Wang X; Wu C; Yang J
    Exp Neurol; 2021 Apr; 338():113598. PubMed ID: 33422553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoginsenoside-F11 Protects against Transient Cerebral Ischemia Injury in Rats Involving Repressing Calcium Overload.
    Zhang T; Wu C; Yang X; Liu Y; Yang H; Yuan L; Liu Y; Sun S; Yang J
    Neuroscience; 2019 Jul; 411():86-104. PubMed ID: 31129202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoginsenoside-F11 promotes functional recovery after transient cerebral ischemia by regulating the microglia/macrophage polarization in rats.
    Hou Y; Yang D; Wang X; Wang H; Zhang H; Wang P; Liu Y; Gao X; Yang J; Wu C
    Int Immunopharmacol; 2021 Oct; 99():107896. PubMed ID: 34246061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salidroside derivative SHPL-49 attenuates glutamate excitotoxicity in acute ischemic stroke via promoting NR2A-CAMKⅡα-Akt /CREB pathway.
    Xie D; Zhang P; You S; Shen Y; Xu W; Zhan C; Zhang J
    Phytomedicine; 2024 Nov; 134():155583. PubMed ID: 39173548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.
    Liu YY; Zhang TY; Xue X; Liu DM; Zhang HT; Yuan LL; Liu YL; Yang HL; Sun SB; Zhang C; Xu HS; Wu CF; Yang JY
    CNS Neurosci Ther; 2017 Jul; 23(7):567-579. PubMed ID: 28485547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoginsenoside-F11 improves long-term neurological function and promotes neurogenesis after transient cerebral ischemia in mice.
    Yuan L; Sun S; Pan X; Zheng L; Li Y; Yang J; Wu C
    Neurochem Int; 2020 Feb; 133():104586. PubMed ID: 31756514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoginsenoside-F11 Accelerates Microglial Phagocytosis of Myelin Debris and Attenuates Cerebral Ischemic Injury Through Complement Receptor 3.
    Liu Y; Wu C; Hou Z; Fu X; Yuan L; Sun S; Zhang H; Yang D; Yao X; Yang J
    Neuroscience; 2020 Feb; 426():33-49. PubMed ID: 31790669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoginsenoside-F11 ameliorates ischemic neuron injury by regulating the polarization of neutrophils and macrophages in vitro.
    Hou Y; Yang D; Zhang Q; Wang X; Yang J; Wu C
    Int Immunopharmacol; 2020 Aug; 85():106564. PubMed ID: 32447220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways.
    Wang X; Wang C; Wang J; Zhao S; Zhang K; Wang J; Zhang W; Wu C; Yang J
    Neuropharmacology; 2014 Apr; 79():642-56. PubMed ID: 24467851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NR2A receptors induces ischemic tolerance through CREB signaling.
    Terasaki Y; Sasaki T; Yagita Y; Okazaki S; Sugiyama Y; Oyama N; Omura-Matsuoka E; Sakoda S; Kitagawa K
    J Cereb Blood Flow Metab; 2010 Aug; 30(8):1441-9. PubMed ID: 20145658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
    Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THSG alleviates cerebral ischemia/reperfusion injury via the GluN2B-CaMKII-ERK1/2 pathway.
    Liu T; Shi J; Wu D; Li D; Wang Y; Liu J; Meng P; Hu L; Fu C; Mei Z; Ge J; Zhang X
    Phytomedicine; 2024 Jul; 129():155595. PubMed ID: 38677275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat.
    Zhang L; Zhao H; Zhang X; Chen L; Zhao X; Bai X; Zhang J
    Brain Res Bull; 2013 Jul; 96():45-53. PubMed ID: 23644141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoginsenoside-F11 ameliorates thromboembolic stroke injury in rats by reducing thromboinflammation.
    Gao Y; Liu Y; Yang X; Zhang T; Hou Y; Wang P; Liu Y; Yuan L; Zhang H; Wu C; Yang J
    Neurochem Int; 2021 Oct; 149():105108. PubMed ID: 34175350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoginsenoside-F11 reduces cognitive impairment and white matter injury in vascular dementia by alleviating autophagy-lysosomal pathway deficiency.
    Wang H; Liu Y; Cui M; Guo Z; Zhao Y; Yang J; Wu C
    Phytomedicine; 2024 Oct; 133():155883. PubMed ID: 39059268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.
    Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG
    Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF/PI3K/Akt and Nogo-A/RhoA/ROCK signaling pathways contribute to neurorestorative effect of Houshiheisan against cerebral ischemia injury in rats.
    Chang J; Yao X; Zou H; Wang L; Lu Y; Zhang Q; Zhao H
    J Ethnopharmacol; 2016 Dec; 194():1032-1042. PubMed ID: 27833029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosurvival NMDA 2A receptor signaling mediates postconditioning neuroprotection in the hippocampus.
    Zhang X; Zhang Q; Tu J; Zhu Y; Yang F; Liu B; Brann D; Wang R
    Hippocampus; 2015 Mar; 25(3):286-96. PubMed ID: 25271147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia-reperfusion injury via regulating NR2B-ERK/CREB signaling.
    Tang X; Xie S; Wang H; Li Y; Lai Z; Sun S; Pan R; Huang Y; Cai J
    Brain Behav; 2023 Feb; 13(2):e2867. PubMed ID: 36585899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.